(Q38018218)

27 August 2017

title

Clinical strategies for the primary health care professional to minimize prescription opioid abuse (English)

1 reference

27 August 2017

1 reference

Jeffrey A Gudin

1

1 reference

27 August 2017

language of work or name

English

0 references

publication date

1 May 2012

1 reference

27 August 2017

published in

Postgraduate Medicine

1 reference

27 August 2017

volume

124

1 reference

27 August 2017

issue

3

1 reference

27 August 2017

page(s)

131-138

1 reference

Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain

27 August 2017

cites work

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.05.2556

Office visits and analgesic prescriptions for musculoskeletal pain in US: 1980 vs. 2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.05.2556

Opioid prescriptions by U.S. primary care physicians from 1992 to 2001.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.05.2556

Volume of prescription opioids used nonmedically in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.05.2556

Substance use disorders in a primary care sample receiving daily opioid therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.05.2556

Reported lifetime aberrant drug-taking behaviors are predictive of current substance use and mental health problems in primary care patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.05.2556

Opioid therapy for chronic nonmalignant pain: a review of the critical issues

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.05.2556

The DIRE score: predicting outcomes of opioid prescribing for chronic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.05.2556

Validation of the revised Screener and Opioid Assessment for Patients with Pain (SOAPP-R).

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.05.2556

Use of opioid medications for chronic noncancer pain syndromes in primary care

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.05.2556

Predicting aberrant behaviors in opioid-treated patients: preliminary validation of the Opioid Risk Tool

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.05.2556

Psychiatric history and psychologic adjustment as risk factors for aberrant drug-related behavior among patients with chronic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.05.2556

Adolescents' motivations to abuse prescription medications.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.05.2556

Motives, diversion and routes of administration associated with nonmedical use of prescription opioids

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.05.2556

Influences of attitudes on family physicians' willingness to prescribe long-acting opioid analgesics for patients with chronic nonmalignant pain

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.05.2556

Long-acting opioids and short-acting opioids: appropriate use in chronic pain management

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.05.2556

Prevalence and characteristics of opioid use in the US adult population

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.05.2556

Cross-Validation of a Screener to Predict Opioid Misuse in Chronic Pain Patients (SOAPP-R).

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.05.2556

Development and validation of the Current Opioid Misuse Measure

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.05.2556

Pain management in primary care: strategies to mitigate opioid misuse, abuse, and diversion

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.05.2556

Managing chronic nonmalignant pain: overcoming obstacles to the use of opioids

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.05.2556

Identifying prescription opioid use disorder in primary care: diagnostic characteristics of the Current Opioid Misuse Measure (COMM)

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.05.2556

Urine drug testing in pain medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.05.2556

A critical assessment of opioid treatment adherence using urine drug testing in chronic pain management

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.05.2556

The opioid contract in the management of chronic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.05.2556

Long-term opioid contract use for chronic pain management in primary care practice. A five year experience

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.05.2556

The opioid renewal clinic: a primary care, managed approach to opioid therapy in chronic pain patients at risk for substance abuse

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.05.2556

Association between opioid prescribing patterns and opioid overdose-related deaths

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.05.2556

Opioid-induced hyperalgesia: a qualitative systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.05.2556

Effects of opioids on the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.05.2556

Prescription OxyContin abuse among patients entering addiction treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.05.2556

A profile of OxyContin addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.05.2556

The abuse potential of Remoxy(®), an extended-release formulation of oxycodone, compared with immediate- and extended-release oxycodone.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.05.2556

Evaluation of the abuse potential of extended release hydromorphone versus immediate release hydromorphone

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.05.2556

Psychiatric and pain characteristics of prescription drug abusers entering drug rehabilitation

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.05.2556

Abuse-deterrent opioid formulations: are they a pipe dream?

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.05.2556

Opioid formulations designed to resist/deter abuse

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.05.2556

21 January 2018

Identifiers

DOI

10.3810/PGM.2012.05.2556

1 reference

27 August 2017

1 reference